| Not Yet Recruiting | A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy NCT05896371 | CHU de Quebec-Universite Laval | Phase 1 / Phase 2 |
| Suspended | Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy NCT05064111 | University of Arizona | — |
| Not Yet Recruiting | Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic NCT06660862 | University of Chicago | Phase 4 |
| Not Yet Recruiting | SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial NCT07280897 | The University of Texas Health Science Center at San Antonio | N/A |
| Not Yet Recruiting | Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Can NCT07264088 | Imperial College London | — |
| Not Yet Recruiting | Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients NCT07441837 | Ankara University | Phase 2 |
| Not Yet Recruiting | Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation NCT07463833 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer NCT07510906 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Withdrawn | Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive H NCT06881823 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer NCT07225309 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients NCT06824818 | University of Chicago | N/A |
| Not Yet Recruiting | Folate Study in Men With Advanced Prostate Cancer NCT06536374 | University of California, San Diego | Phase 2 |
| Not Yet Recruiting | RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer) NCT07440641 | University of Vermont | N/A |
| Not Yet Recruiting | PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy NCT07516808 | Beth Israel Deaconess Medical Center | N/A |
| Not Yet Recruiting | Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metast NCT07310433 | Yung NA | Phase 2 |
| Not Yet Recruiting | Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance NCT07278362 | University of Miami | Phase 4 |
| Not Yet Recruiting | Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening NCT06549036 | VA Office of Research and Development | N/A |
| Not Yet Recruiting | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PR NCT07529418 | Institute of Cancer Research, United Kingdom | — |
| Recruiting | Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) NCT06960798 | University of Oklahoma | — |
| Not Yet Recruiting | Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer NCT07290998 | Alpha Tau Medical LTD. | N/A |
| Not Yet Recruiting | Adaptive Radiotherapy for Safe Hypofractionation NCT07516210 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 |
| Not Yet Recruiting | Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer NCT07518888 | University of Miami | N/A |
| Recruiting | Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Ca NCT07463092 | University of Sao Paulo | N/A |
| Not Yet Recruiting | Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bla NCT07468838 | Institut Cancerologie de l'Ouest | — |
| Not Yet Recruiting | 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients NCT07485881 | Assiut University | — |
| Not Yet Recruiting | PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer NCT07291557 | AHS Cancer Control Alberta | Phase 2 |
| Not Yet Recruiting | Water Vapor Ablation for Prostate Cancer: Long-Term Registry NCT07455058 | Francis Medical Inc. | — |
| Not Yet Recruiting | A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer NCT07468396 | Gan & Lee Pharmaceuticals. | Phase 1 |
| Not Yet Recruiting | CARE Tool Study Aim 3 NCT07296887 | Washington University School of Medicine | N/A |
| Enrolling By Invitation | Natural History Study of Early Life Exposures in Agriculture (ELEA) NCT07328516 | National Cancer Institute (NCI) | — |
| Not Yet Recruiting | Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer NCT07526675 | Benha University | N/A |
| Recruiting | Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer NCT07237269 | University of Nebraska | Phase 2 |
| Not Yet Recruiting | Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Ca NCT07535905 | University Health Network, Toronto | Phase 2 |
| Not Yet Recruiting | Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prost NCT07145437 | Clinique Sainte Clotilde | N/A |
| Not Yet Recruiting | Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Canc NCT04993508 | Heinrich-Heine University, Duesseldorf | N/A |
| Not Yet Recruiting | Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer NCT07476677 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Not Yet Recruiting | HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) NCT07441889 | University of Virginia | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor NCT07535541 | University of Virginia | N/A |
| Not Yet Recruiting | Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolas NCT07455903 | Baptist Health South Florida | Phase 2 |
| Not Yet Recruiting | Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Thera NCT07516704 | Zhongda Hospital | EARLY_Phase 1 |
| Not Yet Recruiting | Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial) NCT07478536 | Insel Gruppe AG, University Hospital Bern | — |
| Not Yet Recruiting | A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk NCT07492381 | ALPFA Medical | N/A |
| Recruiting | Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors NCT07517198 | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | Phase 1 |
| Recruiting | Geriatric Assessment and Technology Evaluation in Prostate Cancer NCT06215508 | University of Chicago | — |
| Recruiting | Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors NCT07436078 | Barbara Ann Karmanos Cancer Institute | N/A |
| Recruiting | PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer NCT07234981 | University of Nebraska | Phase 2 |
| Not Yet Recruiting | Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer NCT07495293 | Yonsei University | Phase 1 |
| Not Yet Recruiting | A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium NCT07480044 | Zhejiang University | N/A |
| Not Yet Recruiting | Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy NCT07475533 | Ankara City Hospital Bilkent | N/A |
| Recruiting | Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratifie NCT07027124 | Icahn School of Medicine at Mount Sinai | Phase 2 |
| Recruiting | PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positiv NCT07426094 | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Phase 2 / Phase 3 |
| Recruiting | 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer NCT07145177 | University of California, San Francisco | Phase 1 |
| Not Yet Recruiting | Effect of Rectus Block Timing on Opioid Use NCT07433140 | Koc University Hospital | N/A |
| Not Yet Recruiting | A Prospective Clinical Trial Evaluating PROSTest, a Blood-Based Molecular Assay, for Risk Stratification and B NCT07454603 | Wren Laboratories LLC | — |
| Not Yet Recruiting | Stem Cells for Erectile Dysfunction Post RALP NCT07048314 | The Methodist Hospital Research Institute | Phase 1 / Phase 2 |
| Recruiting | INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis NCT07398690 | In Gab Jeong, MD | N/A |
| Recruiting | The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Can NCT07468708 | FindCure Biosciences (ZhongShan) Co., Ltd. | EARLY_Phase 1 |
| Recruiting | Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After R NCT07500701 | Samsung Medical Center | Phase 3 |
| Recruiting | SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC NCT07451795 | Fudan University | Phase 2 |
| Not Yet Recruiting | Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer NCT07296042 | Ramsay Générale de Santé | N/A |
| Not Yet Recruiting | A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer NCT07407283 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance NCT07386171 | McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| Not Yet Recruiting | Androgen-responsive POSLUMA-guided Intra-prostatic Boost NCT07393867 | Martin T. King, MD, PhD | Phase 2 |
| Not Yet Recruiting | Axelopran in Advanced Cancers NCT07354919 | HealthPartners Institute | Phase 2 |
| Not Yet Recruiting | Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prio NCT07226713 | Medical College of Wisconsin | Phase 2 |
| Not Yet Recruiting | Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-A NCT07415135 | Zhu Yinjie | Phase 2 |
| Not Yet Recruiting | AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesion NCT07231627 | University of Arkansas | N/A |
| Not Yet Recruiting | Cancer Literacy Education and Awareness Resources for Prostate Care NCT07437482 | Universidad Miguel Hernandez de Elche | — |
| Recruiting | Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES) NCT07427043 | Brigham and Women's Hospital | Phase 3 |
| Recruiting | Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspe NCT07422597 | Norwegian University of Science and Technology | N/A |
| Not Yet Recruiting | ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium NCT07414940 | University College, London | Phase 1 / Phase 2 |
| Not Yet Recruiting | Low-Count Quantitative SPECT for Men Treated With Radium-223 NCT07221825 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | Clinical Trial of TB511 in Advanced Solid Tumors NCT06400160 | Twinpig Biolab, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI NCT07386496 | Chinese University of Hong Kong | N/A |
| Not Yet Recruiting | Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services NCT07407686 | Royal Marsden NHS Foundation Trust | — |
| Withdrawn | Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology NCT05046782 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer NCT07093177 | University of Utah | N/A |
| Recruiting | Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance NCT07285057 | Icahn School of Medicine at Mount Sinai | Phase 2 |
| Not Yet Recruiting | Lab Research Using Mini-tumors to Study Prostate Cancer Treatments NCT07004582 | Maastricht Radiation Oncology | — |
| Active Not Recruiting | Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer NCT07236112 | C Ray Therapeutics | Phase 1 |
| Active Not Recruiting | The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy NCT06964412 | Brigham and Women's Hospital | N/A |
| Recruiting | Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer NCT07325721 | Medical University of South Carolina | Phase 2 |
| Not Yet Recruiting | Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic T NCT07387263 | Unity Health Toronto | N/A |
| Not Yet Recruiting | A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS NCT06906471 | Antelope Surgical Solutions, Inc | Phase 1 / Phase 2 |
| Not Yet Recruiting | Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy NCT06637943 | Konkuk University Medical Center | — |
| Not Yet Recruiting | Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stres NCT07102212 | Ohio State University Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions ( NCT07483658 | CHU de Quebec-Universite Laval | N/A |
| Not Yet Recruiting | Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localize NCT07300566 | Joelle Helou | Phase 2 |
| Not Yet Recruiting | SL-28 for Advanced Solid Tumours NCT07341737 | Second Life Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial NCT07227077 | Medical College of Wisconsin | N/A |
| Not Yet Recruiting | Sequential bpMRI for Suspicious Prostate Lesions NCT07332832 | Peking University First Hospital | — |
| Recruiting | A Phase I Trial of A-CAR032 in Participants With mCRPC NCT07344311 | Shanghai AbelZeta Ltd. | Phase 1 |
| Not Yet Recruiting | iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prosta NCT07105020 | M.D. Anderson Cancer Center | N/A |
| Not Yet Recruiting | Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Canc NCT07112612 | Anhui Medical University | — |
| Recruiting | A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery NCT07188064 | Sir Mortimer B. Davis - Jewish General Hospital | N/A |
| Enrolling By Invitation | Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials NCT07474051 | AvenCell Therapeutics, Inc. | — |
| Recruiting | ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 NCT07407608 | University of Milano Bicocca | — |
| Recruiting | Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology NCT07432360 | Virdx, Inc. | — |
| Recruiting | Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics NCT07112599 | Anhui Medical University | — |
| Recruiting | A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer NCT07339267 | Astellas Pharma Global Development, Inc. | Phase 1 |
| Not Yet Recruiting | Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer NCT07365397 | Shanghai Zhongshan Hospital | N/A |
| Not Yet Recruiting | Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treat NCT07311915 | Zhongda Hospital | N/A |
| Recruiting | Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Me NCT06957691 | Shehzad Basaria, M.D. | Phase 2 |
| Recruiting | Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer NCT07245745 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Not Yet Recruiting | Prostate Cancer Early Detection Using Serial MRI Examinations NCT07355504 | University Hospital, Grenoble | N/A |
| Recruiting | A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer NCT07335796 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Not Yet Recruiting | A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Give NCT07336446 | AstraZeneca | Phase 1 / Phase 2 |
| Recruiting | Effect Of Trendelenburg Position And Pneumoperitoneum On Optic Nerve Sheath Diameter In Robot-Assisted Prostat NCT07491198 | Ege University | — |
| Not Yet Recruiting | Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019 NCT07282197 | Peking University First Hospital | Phase 2 |
| Recruiting | The Impact of Force Feedback in the dV5 Robotic Surgical System on Learning Curve and Safety in Robot-Assisted NCT07247175 | Seong Soo Jeon | Phase 2 |
| Recruiting | Focal or Radical Therapy: a Lesion-based Molecular Evaluation in Prostate Cancer NCT07282808 | Singapore General Hospital | N/A |
| Not Yet Recruiting | Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic NCT07381582 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Withdrawn | Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer NCT05333432 | Assistance Publique - Hôpitaux de Paris | N/A |
| Withdrawn | Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer NCT04243473 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Recruiting | Cognitive and Fusion Prostatic Biopsy NCT07306741 | Menoufia University | N/A |
| Not Yet Recruiting | Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local Anesthesi NCT07069049 | Shanghai University of Traditional Chinese Medicine | N/A |
| Recruiting | Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence NCT07426861 | Royal College of Surgeons, Ireland | N/A |
| Recruiting | Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors NCT07358806 | Oscotec Inc. | Phase 1 |
| Recruiting | Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise NCT07243834 | Royal Marsden NHS Foundation Trust | N/A |
| Recruiting | Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray NCT07293585 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Not Yet Recruiting | PSMA-PET/MRI-Ultrasound Multimodal Fusion Navigation for Da Vinci Robot-Assisted Radical Prostatectomy: A Rand NCT07272317 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Recruiting | Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement NCT06200259 | Covenant Health Cancer Center | N/A |
| Recruiting | A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer NCT07230106 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Recruiting | The Florida ASCENT Study NCT07042243 | University of Florida | N/A |
| Not Yet Recruiting | CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE NCT06773806 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Not Yet Recruiting | A Prospective Evaluation of Early Acupuncture for Immediate Continence Enhancement After Prostatectomy NCT07239518 | Bin Xu | N/A |
| Not Yet Recruiting | The Influence of Music on perceiVed paIn and leVels of Anxiety whiLe unDergoing transperIneal Prostate Biopsy: NCT07234097 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | N/A |
| Not Yet Recruiting | Minimal Residual Disease in Solid Malignancies NCT07268469 | European Institute of Oncology | N/A |
| Recruiting | Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients NCT06138067 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Recruiting | Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directe NCT07210086 | City of Hope Medical Center | Phase 2 |
| Not Yet Recruiting | Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy NCT07245342 | Shanghai University of Traditional Chinese Medicine | N/A |
| Recruiting | Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized The NCT07344363 | Centro di Riferimento Oncologico - Aviano | — |
| Recruiting | Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Sp NCT07231159 | AdventHealth | — |
| Recruiting | Holistic Acupuncture for Patients With Chemotherapy Induced Nausea NCT07201194 | Vejle Hospital | N/A |
| Not Yet Recruiting | Standardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen NCT07064811 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | N/A |
| Recruiting | Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early NCT07313241 | University of Texas Southwestern Medical Center | Phase 2 |
| Recruiting | GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies NCT07258056 | Mads Ryo Jochumsen | N/A |
| Not Yet Recruiting | Memantine Hydrochloride in Prostate Cancer Patients NCT07164794 | Bin Xu | Phase 2 |
| Active Not Recruiting | Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer NCT06434649 | Ning Xu | N/A |
| Recruiting | Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PE NCT06917781 | Institut Claudius Regaud | N/A |
| Enrolling By Invitation | Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer NCT06935097 | M.D. Anderson Cancer Center | N/A |
| Recruiting | RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer NCT06856694 | Cedars-Sinai Medical Center | N/A |
| Not Yet Recruiting | A Study of DXC014 in Patients With Advanced Solid Tumors. NCT07177937 | Hangzhou DAC Biotechnology Co., Ltd. | Phase 1 |
| Recruiting | Exercise in Prostate Cancer NCT06165302 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Recruiting | Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Can NCT07014618 | University of Oklahoma | — |
| Recruiting | PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultraso NCT07184970 | NYU Langone Health | — |
| Recruiting | Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors NCT07001241 | University of Colorado, Denver | Phase 2 |
| Recruiting | Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment NCT07011342 | Hackensack Meridian Health | N/A |
| Not Yet Recruiting | MRI-guided Locoregional SBRT Prostate Program NCT07132073 | Clinica Universidad de Navarra, Universidad de Navarra | N/A |
| Not Yet Recruiting | High-intensity Focused Ultrasound Combined With Novel Hormone Therapy in Advanced Prostate Cancer NCT07126093 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Not Yet Recruiting | MRI-guided Ultrahypofractionated SBRT Prostate Program NCT07132658 | Clinica Universidad de Navarra, Universidad de Navarra | N/A |
| Not Yet Recruiting | Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk NCT06945172 | GCS Ramsay Santé pour l'Enseignement et la Recherche | N/A |
| Recruiting | A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Ad NCT07192614 | AstraZeneca | Phase 1 / Phase 2 |
| Recruiting | This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enza NCT07028853 | Pfizer | Phase 3 |
| Recruiting | Stratagen Quantitative Prostate MRI Platform Pilot Study NCT06985238 | Stratagen Bio, Inc. | N/A |
| Recruiting | NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway NCT06672926 | University Hospitals of North Midlands NHS Trust | — |
| Recruiting | Circulating Tumor DNA in High Risk Localized Prostate Cancer NCT07222436 | University of Pittsburgh | — |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Not Yet Recruiting | LTFU for All Cell and Gene Therapy Studies NCT06194461 | AstraZeneca | — |
| Recruiting | Detection of Minimal Residual Disease Post-prostatectomy NCT07334275 | Radboud University Medical Center | — |
| Recruiting | Effect of Text Message Reminders on M-ISI Score After Prostate Surgery NCT07071207 | University of Rochester | N/A |
| Not Yet Recruiting | Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer NCT06355050 | Jena University Hospital | — |
| Recruiting | Investigation of Impact of AI on Prostate Cancer Workflow NCT07084779 | Case Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Pros NCT05576766 | Peking University First Hospital | N/A |
| Not Yet Recruiting | Identifying Fundamental Mechanisms of Skeletal Muscle Ageing in Older Men Undergoing Androgen Deprivation Ther NCT07134439 | Guy's and St Thomas' NHS Foundation Trust | — |
| Suspended | Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer NCT05361915 | Sorrento Therapeutics, Inc. | Phase 2 |
| Recruiting | 68Ga-XACP3 PET/CT in Prostate Cancer NCT07242014 | The First Affiliated Hospital of Xiamen University | N/A |
| Not Yet Recruiting | Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI NCT07040501 | Case Comprehensive Cancer Center | N/A |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic So NCT07181473 | Phrontline Biopharma | Phase 1 |
| Recruiting | IDOV-Immune for Advanced Solid Tumors NCT06910657 | ViroMissile, Inc. | Phase 1 |
| Recruiting | Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors NCT06651359 | University of Oklahoma | N/A |
| Recruiting | PSMA PET Combined With MRI for the Detection of PCa NCT07052214 | Telix Pharmaceuticals (Innovations) Pty Limited | Phase 3 |
| Recruiting | Periprostatic Neurolysis in Prostate Cancer NCT07100847 | University of Texas Southwestern Medical Center | Phase 1 |
| Recruiting | Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Hea NCT07109427 | Washington University School of Medicine | N/A |
| Recruiting | COMPASS Study for Metastatic Castration-resistant Prostate Cancer NCT07050433 | Duke University | — |
| Recruiting | A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk NCT06952803 | AstraZeneca | Phase 3 |
| Not Yet Recruiting | A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients NCT06875297 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Not Yet Recruiting | ExosomeDx in MRI-negative Men With High PSA NCT06966089 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | Ga-68 PSMA PET/CT vs mpMRI in Cognitive Prostate Biopsy NCT07533344 | Fatih Sultan Mehmet Training and Research Hospital | — |
| Not Yet Recruiting | Prostate Cancer Study of Patient Experiences NCT07096596 | Ankara University | — |
| Recruiting | Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS) NCT06804785 | Northwestern University | — |
| Not Yet Recruiting | Creative Arts Therapy on Body Image, Self-esteem, Anxiety and Depression in Post-Treatment Prostate Cancer Pat NCT07015866 | The Hong Kong Polytechnic University | N/A |
| Recruiting | Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC NCT07172685 | Qilu Hospital of Shandong University | N/A |
| Recruiting | Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended NCT07115992 | Ruijin Hospital | N/A |
| Recruiting | Connect2Care: Prostate Cancer Education and Screenings for African American Men NCT07055165 | University of Oklahoma | N/A |
| Completed | A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensi NCT07086651 | Pfizer | — |
| Recruiting | Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051 | Natera, Inc. | — |
| Recruiting | Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Alg NCT07484971 | Société Algérienne de Formation et Recherche en Oncologie | — |
| Recruiting | Occupational Situation and Return to Work of Urological Patients NCT07088536 | Jagiellonian University | — |
| Completed | Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico. NCT07134504 | Instituto Mexicano del Seguro Social | — |
| Completed | Efficacy Of Acupuncture in Pain and Anxiety During Transperineal Prostate Biopsy: A Prospective, Randomized, S NCT06987071 | Medipol University | N/A |
| Active Not Recruiting | A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer. NCT06733337 | Pfizer | — |
| Recruiting | A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC NCT06826768 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 NCT07054346 | Thomas Hope | Phase 1 |
| Recruiting | Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy NCT06908694 | Hamilton Health Sciences Corporation | Phase 4 |
| Recruiting | Akkermansia Muciniphilia and Metabolic Side Effects of ADT NCT05802121 | Western University | EARLY_Phase 1 |
| Recruiting | Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Canc NCT06759701 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Not Yet Recruiting | TULIP ReTrain Study NCT06974539 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Withdrawn | Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer NCT06795178 | Foresee Pharmaceuticals Co., Ltd. | Phase 3 |
| Recruiting | Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC NCT06855277 | Novartis Pharmaceuticals | Phase 3 |
| Not Yet Recruiting | Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III) NCT06914544 | University Hospital Schleswig-Holstein | N/A |
| Not Yet Recruiting | Prostate Irreversible Electroporation Study NCT06886321 | Chinese University of Hong Kong | N/A |
| Recruiting | Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russ NCT07146113 | AstraZeneca | — |
| Recruiting | Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Pro NCT07052578 | AstraZeneca | — |
| Active Not Recruiting | Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy NCT05761912 | Shanghai Minhang Central Hospital | — |
| Completed | A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects NCT07014488 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Recruiting | A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer NCT07005154 | Astellas Pharma Global Development, Inc. | Phase 2 |
| Recruiting | Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach f NCT06955910 | Istituto Oncologico Veneto IRCCS | — |
| Not Yet Recruiting | Proteomic Analysis of Patients Undergoing Bariatric Surgery NCT06787807 | Universidade Federal de Pernambuco | N/A |
| Recruiting | Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer NCT06990542 | University of California, San Diego | Phase 2 |
| Recruiting | A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmaco NCT07149831 | Sinotau Pharmaceutical Group | Phase 1 |
| Recruiting | Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer NCT05873192 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study NCT06636526 | Institute of Cancer Research, United Kingdom | — |
| Recruiting | Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Ca NCT06877598 | University Health Network, Toronto | — |
| Withdrawn | Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectom NCT04569461 | Duke University | Phase 2 |
| Active Not Recruiting | Surveillance or Focal Therapy NCT07207902 | Kaiser Permanente | N/A |
| Recruiting | The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication Development in Transr NCT06998121 | Mersin University | N/A |
| Not Yet Recruiting | The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture NCT06901492 | Nanjing First Hospital, Nanjing Medical University | N/A |
| Withdrawn | Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer NCT06795191 | Foresee Pharmaceuticals Co., Ltd. | Phase 3 |
| Not Yet Recruiting | State of Play of Physiotherapy in the Postoperative Management of Prostate Cancer : Prospective, Monocentric, NCT06815055 | Centre Hospitalier de Roubaix | — |
| Recruiting | The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patie NCT07057375 | Chinese University of Hong Kong | N/A |
| Recruiting | Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer NCT07015138 | Peking University First Hospital | N/A |
| Recruiting | Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer NCT07032584 | University of Utah | N/A |
| Recruiting | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors NCT05974774 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Recruiting | Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 NCT06972628 | Ebrahim S Delpassand | Phase 2 |
| Recruiting | A Study of Changes to Prostate Procedures NCT06986083 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Recruiting | 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of NCT06970847 | Clarity Pharmaceuticals Ltd | Phase 3 |
| Recruiting | A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors NCT06926283 | Hangzhou DAC Biotechnology Co., Ltd. | Phase 1 |
| Recruiting | Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely D NCT07180381 | St. Antonius Hospital | N/A |
| Recruiting | High Intensity Focused Ultrasound in Prostate Cancer NCT06402357 | University of Florida | Phase 2 |
| Active Not Recruiting | The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Susp NCT06824259 | Peking University First Hospital | N/A |
| Recruiting | A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients NCT06970119 | Yunhe Pharmaceutical (Tianjin) Co., Ltd | Phase 1 / Phase 2 |
| Recruiting | Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatec NCT07141121 | Icahn School of Medicine at Mount Sinai | N/A |
| Recruiting | A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) NCT06925737 | Merck Sharp & Dohme LLC | Phase 3 |
| Recruiting | Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy NCT06450106 | SURGE Therapeutics | Phase 1 |
| Recruiting | Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA NCT06600698 | Milton S. Hershey Medical Center | Phase 1 / Phase 2 |
| Recruiting | Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation NCT05790213 | University of Chicago | Phase 2 |
| Recruiting | Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies NCT06907446 | University of California, Davis | N/A |
| Not Yet Recruiting | High-resolution Intra-operative PSMA PET-CT in Prostate Cancer NCT06298838 | IRCCS San Raffaele | — |
| Recruiting | MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster R NCT06954337 | Memorial Sloan Kettering Cancer Center | N/A |
| Withdrawn | 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study NCT05707182 | University of Alabama at Birmingham | EARLY_Phase 1 |
| Withdrawn | Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repai NCT06527690 | Latin American Cooperative Oncology Group | Phase 2 |
| Recruiting | Designing Visual Tools to Enhance Cancer Surgeon Decision-making NCT06965192 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cance NCT07117760 | First Affiliated Hospital of Fujian Medical University | Phase 1 / Phase 2 |
| Recruiting | Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single- NCT07163910 | baotai Liang | Phase 2 |
| Not Yet Recruiting | Focal Laser Ablation in Prostate Cancer NCT06916013 | Ain Shams University | — |
| Recruiting | A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521 | Tanabe Pharma America, Inc. | Phase 1 / Phase 2 |
| Recruiting | Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer NCT06517901 | Albany Medical College | N/A |
| Recruiting | Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Po NCT06487507 | University of Miami | N/A |
| Recruiting | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction NCT06462963 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Recruiting | Clinical Utility of ClarityDX Prostate NCT06678828 | Nanostics | N/A |
| Recruiting | Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patie NCT06625970 | UNICANCER | Phase 3 |
| Completed | A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer NCT06840535 | Philogen S.p.A. | Phase 1 |
| Active Not Recruiting | Leveraging EA8191 to Assess AI-Augmented EHR Abstraction NCT06561230 | University of Pennsylvania | — |
| Not Yet Recruiting | Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients with Intermediate or NCT06678126 | Scott Tyldesley | Phase 2 |
| Active Not Recruiting | European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametr NCT06935487 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Not Yet Recruiting | Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. NCT06922903 | Yunhe Pharmaceutical (Tianjin) Co., Ltd | Phase 3 |
| Not Yet Recruiting | IONM During Radical Prostatectomy NCT06950216 | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | N/A |
| Recruiting | Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer NCT07363486 | First Affiliated Hospital of Fujian Medical University | Phase 1 / Phase 2 |
| Recruiting | Anxiety in Patients Under Active Surveillance for Localized Prostate Cancer and Their Partners. NCT07351461 | University Hospital, Lille | — |
| Active Not Recruiting | Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups NCT07048613 | Superior University | — |
| Recruiting | Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Pros NCT07115277 | Sinotau Pharmaceutical Group | N/A |
| Recruiting | Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329 | Brian Henick, MD | Phase 1 |
| Completed | Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D NCT06783088 | Central Hospital, Nancy, France | — |
| Recruiting | Evaluating Tolerability of ePUHRT With Brachytherapy Boost NCT06817668 | Indiana University | N/A |
| Recruiting | Castrate Resistant Prostate Cancer Enhertu Therapy NCT06610825 | Washington D.C. Veterans Affairs Medical Center | Phase 2 |
| Recruiting | In Vivo Dosimetry for Brachytherapy Study NCT06863090 | East and North Hertfordshire NHS Trust | — |
| Not Yet Recruiting | Feasibility of a Remotely-Delivered Resistance Training Program for Cognitive Function in Men Living With and NCT06828003 | University of Toronto | N/A |
| Recruiting | Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study NCT06719206 | Mälardalen University | N/A |
| Not Yet Recruiting | Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection NCT06453785 | Imperial College London | N/A |
| Recruiting | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation NCT06778863 | Clasp Therapeutics, Inc. | Phase 1 |
| Recruiting | Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive NCT06780670 | Novartis Pharmaceuticals | Phase 2 / Phase 3 |
| Enrolling By Invitation | Prostate Cancer Screening: a Pilot Study NCT06238661 | Fondazione del Piemonte per l'Oncologia | N/A |
| Active Not Recruiting | COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer NCT06627530 | Brazilian Clinical Research Institute | Phase 4 |
| Enrolling By Invitation | AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP） NCT07082049 | Fudan University | N/A |
| Recruiting | Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 NCT06785636 | Pathos AI, Inc. | Phase 1 / Phase 2 |
| Recruiting | SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization NCT06389097 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Not Yet Recruiting | Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer NCT06837896 | Qilu Pharmaceutical Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Focal Therapy in Localized Prostate Cancer: a Prospective Registry NCT06772116 | Institut Mutualiste Montsouris | — |
| Recruiting | Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions NCT06841211 | Peking University First Hospital | N/A |
| Withdrawn | Using Meditation for Oncology Anxiety NCT04312191 | Mellar Davis MD | N/A |
| Not Yet Recruiting | Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Re NCT06762925 | Xijing Hospital | — |
| Recruiting | A Study of SHR-4394 Injection in Subjects With Prostate Cancer NCT06783829 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patie NCT06783153 | Mansoura University | Phase 1 / Phase 2 |
| Recruiting | Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions NCT06638541 | Royal Marsden NHS Foundation Trust | N/A |
| Recruiting | Hypofractionated WPPT With HDR Boost NCT06591819 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Recruiting | 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer NCT06449781 | Maria Sklodowska-Curie National Research Institute of Oncology | Phase 2 |
| Completed | Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial NCT06661902 | University of Washington | Phase 1 / Phase 2 |
| Recruiting | Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial NCT06303622 | Chinese University of Hong Kong | N/A |
| Completed | Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidem NCT06902441 | University Hospital, Caen | — |
| Recruiting | A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients W NCT05726292 | University of Chicago | Phase 2 |
| Recruiting | Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System NCT06807359 | SpectraCure AB | Phase 1 / Phase 2 |
| Recruiting | Internet-based Support for Adjustment to Prostate Cancer NCT06766526 | Linkoeping University | N/A |
| Recruiting | Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Pro NCT05958082 | Henry Ford Health System | N/A |
| Recruiting | Comparing Rezum and Urolift NCT06820606 | Chinese University of Hong Kong | N/A |
| Withdrawn | Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance NCT03495479 | Omnitura Therapeutics, Inc. | — |
| Recruiting | Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663 | RenJi Hospital | Phase 2 / Phase 3 |
| Recruiting | PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer NCT06652607 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer NCT06754085 | HTA Co., Ltd. | Phase 3 |
| Recruiting | Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metast NCT06756334 | Anhui Provincial Hospital | EARLY_Phase 1 |